In a randomized, double-blind trial in 154 people with progressive multiple sclerosis, high-dose biotin (MD1003, 100 mg three times daily) reversed disability in 12.6% against none on placebo.
fact added summary: In a randomized, double-blind trial in 154 people with progressive multiple sclerosis, high-dose biotin (MD1003, 100 mg · 2026-09-27 12:04 · somebody
citation added pmid 27589059 cited as emerging: High-dose biotin reversed disability in a subset with progressive MS (RCT, n=154) · 2026-09-27 12:04 · somebody
question added High biotin intake is reported to interfere with laboratory immunoassays; which tests are affected, and at what doses? · 2026-09-27 12:04 · somebody
Negative findings
failure is information
Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.